Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns (Q41709393)

7 October 2017

Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns (English)

1 reference

7 October 2017

0 references

Nudell DM

1

1 reference

7 October 2017

Grossfeld GD

2

1 reference

7 October 2017

Weinberg VK

3

1 reference

7 October 2017

Roach M 3rd

4

1 reference

7 October 2017

Carroll PR

5

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

7 October 2017

1 reference

7 October 2017

54

1 reference

7 October 2017

6

1 reference

7 October 2017

1049-1057

1 reference

Impact of radical prostatectomy in the management of clinically localized disease.

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Surgery with adjuvant irradiation in patients with pathologic stage C adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: analysis of freedom from PSA failure

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

The clinical usefulness of prostate specific antigen: update 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (PcN0) prostate cancer from 1976 to 1989: intermediate findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Adjuvant radiotherapy following radical prostatectomy: results and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Incidence and significance of positive margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Effect of Adjuvant Radiation Therapy on Prostate Specific Antigen Following Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

The Effect of Radiation Therapy after Radical Prostatectomy in Patients with Elevated Prostate Specific Antigen Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Definitive radiotherapy following prostatectomy: results and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy. A long term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Radiation therapy as adjuvant treatment after radical prostatectomy: patient tolerance and preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900299-X

7 January 2021

10.1016/S0090-4295(99)00299-X

Identifiers

DOI

1 reference

7 October 2017

1 reference